Rennovia Overview
- Founded
-
2009
- Status
-
Out of Business
- Employees
-
50
- Latest Deal Type
-
Out of Business
Rennovia General Information
Description
Developer of novel processes designed to offer cost-advantaged production of chemicals. The company's processes offer approaches to produce bio-based chemicals from low-cost renewable feedstocks using chemical catalytic process technology, enabling businesses to produce bio-based chemicals.
Contact Information
Primary Industry
Specialty Chemicals
Other Industries
Other Chemicals and Gases
Primary Office
- 3040 Oakmead Village Drive
- Santa Clara, CA 95051
- United States
Rennovia Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Out of Business | 09-Mar-2018 | 0000 | Completed | Out of Business | ||
| 4. Later Stage VC | 01-Feb-2017 | 000 | 0000 | Completed | Generating Revenue | |
| 3. Debt - General | 01-Apr-2015 | 000 | 0000 | Completed | Generating Revenue | |
| 2. Early Stage VC (Series B) | 14-Feb-2014 | $25M | $35M | 00000 | Completed | Startup |
| 1. Early Stage VC (Series A) | 02-Jan-2013 | $10M | $10M | 000.00 | Completed | Startup |
Rennovia Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | 00,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 000 |
| Series A | 00,000,000 | 00.000000 | 00 | 00 | 00 | 00 | 00 | 00.00 |
Rennovia Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer of novel processes designed to offer cost-advantaged production of chemicals. The company's processes offer ap
Specialty Chemicals
Santa Clara, CA
50
As of 2015
0000
00000000 00
0000
000000
rure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat null
00000 000000000 000
Cardiff, United Kingdom
00
As of 0000
00.00
0000-00-00
000000&0
000000
ore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco lab
00000 00000000000
Ann Arbor, MI
00
As of 0000
00.00
0000000000 0
00.00
Add Comparison
Rennovia Competitors (11)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Biocatalysts | Corporate Backed or Acquired | Cardiff, United Kingdom | 00 | 000000&0 | ||
| 000000 0000000000 | Venture Capital-Backed | Ann Arbor, MI | 00 | 00.00 | 0000000000 0 | 00.00 |
| 00000000000000 | Venture Capital-Backed | Paris, France | 00 | 0000 | 00000000000 | 0000 |
| 0000000000 | Venture Capital-Backed | Pearl River, NY | 00 | 000.00 | 0000000000 0 | 000.00 |
| 000000 | Venture Capital-Backed | Visalia, CA | 00 | 00000 | 000000 - 000 | 00000 |
Rennovia Patents
Rennovia Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2015517977-A | Production of caprolactam from adipic acid. | Pending | 23-Feb-2012 | 0000000000 | |
| US-20130225785-A1 | Production of caprolactam from adipic acid | Active | 23-Feb-2012 | 0000000000 | |
| US-8946411-B2 | Production of caprolactam from adipic acid | Active | 23-Feb-2012 | 0000000000 | |
| EP-2817293-A1 | Production of caprolactam from adipic acid | Inactive | 23-Feb-2012 | 000000000 | |
| US-9487465-B2 | Process for the separation of mono- and di-carboxylic acid compounds | Active | 14-Dec-2011 | B01D15/363 |
Rennovia Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
